Ardelyx

A biopharmaceutical company in Fremont is seeking an Associate Director of Medical Communications. The role involves creating and executing medical communication strategies, developing MSL materials, and supporting medical activities at conferences. Candidates should have a Master's or advanced degree and 6-8 years of relevant experience in Medical Affairs or scientific communications. The position offers a competitive salary range of $194,000-$230,000 and a robust benefits package, including generous paid leave and a 401(k) plan. #J-18808-Ljbffr

Description Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Associate Director, Medical Communications is responsible for supporting the development and execution of strategic, integrated medical communication initiatives across marketed products and pipeline indications. This role plays a key part in translating complex scientific data into clear,...

Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first‑class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary The Associate Director, Medical Communications is responsible for supporting the development and execution of strategic, integrated medical communication initiatives across marketed products and pipeline indications. This role plays a key part in translating complex scientific data into clear, compelling, and...

Description Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Associate Director, Medical Communications is responsible for supporting the development and execution of strategic, integrated medical communication initiatives across marketed products and pipeline indications. This role plays a key part in translating complex scientific data into clear,...

Description Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: The Associate Director, Medical Communications is responsible for supporting the development and execution of strategic, integrated medical communication initiatives across marketed products and pipeline indications. This role plays a key part in translating complex scientific data into clear,...